erlotinib hydrochloride has been researched along with prednisone in 1 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (prednisone) | Trials (prednisone) | Recent Studies (post-2010) (prednisone) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 41,222 | 5,274 | 8,409 |
Protein | Taxonomy | erlotinib hydrochloride (IC50) | prednisone (IC50) |
---|---|---|---|
Glucocorticoid receptor | Homo sapiens (human) | 1.146 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 1.146 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 1.146 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 1.146 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 1.146 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di Martino, V; Prati, C; Verhoeven, F; Weil-Verhoeven, D; Wendling, D | 1 |
1 other study(ies) available for erlotinib hydrochloride and prednisone
Article | Year |
---|---|
Polymyalgia rheumatica occurrence under multikinase inhibitors (sorafenib and erlotinib) treatment.
Topics: Aged; Carcinoma, Hepatocellular; Erlotinib Hydrochloride; Glucocorticoids; Humans; Liver Neoplasms; Male; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prednisone; Protein Kinase Inhibitors; Sorafenib | 2019 |